Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Liabilities and Shareholders Equity: 2009-2024

Historic Liabilities and Shareholders Equity for Rockwell Medical (RMTI) over the last 16 years, with Dec 2024 value amounting to $59.2 million.

  • Rockwell Medical's Liabilities and Shareholders Equity rose 0.70% to $57.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $223.3 million, marking a year-over-year increase of 4.82%. This contributed to the annual value of $59.2 million for FY2024, which is 13.48% up from last year.
  • As of FY2024, Rockwell Medical's Liabilities and Shareholders Equity stood at $59.2 million, which was up 13.48% from $52.2 million recorded in FY2023.
  • Rockwell Medical's 5-year Liabilities and Shareholders Equity high stood at $77.7 million for FY2020, and its period low was $46.6 million during FY2022.
  • In the last 3 years, Rockwell Medical's Liabilities and Shareholders Equity had a median value of $52.2 million in 2023 and averaged $52.7 million.
  • Its Liabilities and Shareholders Equity has fluctuated over the past 5 years, first skyrocketed by 75.44% in 2020, then tumbled by 37.52% in 2021.
  • Yearly analysis of 5 years shows Rockwell Medical's Liabilities and Shareholders Equity stood at $77.7 million in 2020, then tumbled by 37.52% to $48.6 million in 2021, then decreased by 3.99% to $46.6 million in 2022, then rose by 11.88% to $52.2 million in 2023, then grew by 13.48% to $59.2 million in 2024.